Curis Q1 EPS $(0.18) Misses $(0.16) Estimate, Sales $2.10M Miss $2.40M Estimate
Curis (NASDAQ:CRIS) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 63.64 percent decrease over losses of $(0.11) per share from the same
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Earnings Outlook For Curis
Curis (NASDAQ:CRIS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement.
Analysts estimate that Curis will report an earnings per share (EPS) of $-0.16.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
After Leukemia Trial, FDA Puts Partial Hold On Curis’ Lymphoma Study
The FDA has placed a partial clinical hold on Curis Inc’s (NASDAQ:CRIS) TakeAim Lymphoma study. The TakeAim Lymphoma study is a…